Related Experiment Videos
Update on antifibrotic use in glaucoma surgery, including use in trabeculectomy and glaucoma drainage implants and
Patricia S Yoon1, Kuldev Singh
1Stanford University, School of Medicine, Stanford, California, USA. psyoon@stanford.edu
Purpose Of Review:
This paper summarizes the use of antifibrotic agents adjunctive to glaucoma surgery, reviews recently published studies that address current use of these antifibrotics, and reviews new methods of wound modulation.
Recent Findings:
The use of antifibrotic agents, namely, 5-fluorouracil and mitomycin C, in conjunction with glaucoma surgery has resulted in lower postoperative intraocular pressures after trabeculectomy or combined cataract and glaucoma surgery. Mixed results have been seen when these agents are used with glaucoma drainage device surgery. The use of antifibrotic agents has also created and increased complications. Therefore, methods of antifibrotic use have become more refined and modified for specific circumstances. Promising new wound modulation agents, such as CAT-152, are currently under study.
Summary:
Antifibrotics are potent adjuncts to glaucoma surgery, but along with their beneficial use are risks that need to be considered. While we continue to look for more efficacious agents and methods to treat glaucoma, we must continue to modify techniques with the individual patient's best interest in mind.
Insights
Antifibrotic agents like 5-fluorouracil and mitomycin C can lower eye pressure after glaucoma surgery, but may increase complications. New agents and refined techniques are being developed for better outcomes.
Area of Science:
- Ophthalmology
- Surgical Innovation
Background:
- Glaucoma surgery aims to reduce intraocular pressure.
- Fibrosis can impede surgical success, leading to elevated eye pressure.
- Antifibrotic agents are used to modulate wound healing post-surgery.
Purpose of the Study:
- To review the use of antifibrotic agents in glaucoma surgery.
- To examine recent studies on antifibrotic efficacy and complications.
- To explore novel wound modulation techniques.
Main Methods:
- Literature review of antifibrotic agents (5-fluorouracil, mitomycin C) in glaucoma surgery.
- Analysis of studies on glaucoma drainage device surgery outcomes.
- Evaluation of new wound modulation agents.
Main Results:
- Antifibrotics effectively lower intraocular pressure after trabeculectomy and combined surgeries.
- Mixed results reported for glaucoma drainage device surgery.
- Increased complications associated with antifibrotic use necessitate refined application methods.
- New agents like CAT-152 show promise.
Conclusions:
- Antifibrotics are valuable adjuncts to glaucoma surgery, balancing benefits against risks.
- Continued research into efficacious agents and refined surgical techniques is crucial.
- Individualized patient care and technique modification are essential for optimal glaucoma management.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview